Hepatitis C virus in blood donation, The Lancet, vol.365, issue.9456, pp.276-278, 2005. ,
DOI : 10.1016/S0140-6736(05)70165-3
T-cell responses and previous exposure to hepatitis C virus in indeterminate blood donors, The Lancet, vol.365, issue.9456, pp.327-329, 2005. ,
DOI : 10.1016/S0140-6736(05)70197-5
Clearance of low levels of HCV viremia in the absence of a strong adaptive immune response, Virology Journal, vol.4, issue.1, pp.1-11, 2007. ,
DOI : 10.1186/1743-422X-4-58
Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C, Nature medicine, vol.6, pp.578-582, 2000. ,
Exposed or not exposed-that is the question: evidence for resolving and abortive hepatitis C virus infections in blood donors, Transfusion, vol.49, pp.1277-1281, 2009. ,
Immunological determinants of the outcomes from primary hepatitis C infection, Cellular and Molecular Life Sciences, vol.66, issue.5, pp.733-756, 2009. ,
DOI : 10.1007/s00018-008-8270-4
Cellular Immune Responses in Seronegative Sexual Contacts of Acute Hepatitis C Patients, Journal of Virology, vol.78, issue.22, pp.11252-11258, 2004. ,
DOI : 10.1128/JVI.78.22.12252-12258.2004
Molecular Mimicry of Human Cytochrome P450 by Hepatitis C Virus at the Level of Cytotoxic T Cell Recognition, The Journal of Experimental Medicine, vol.68, issue.2, pp.169-176, 1999. ,
DOI : 10.1056/NEJM199511023331816
Cross-Reactivity between Hepatitis C Virus and Influenza A Virus Determinant-Specific Cytotoxic T Cells, Journal of Virology, vol.75, issue.23, pp.11392-11400, 2001. ,
DOI : 10.1128/JVI.75.23.11392-11400.2001
The influence of T cell cross-reactivity on HCV-peptide specific human T cell response, Hepatology, vol.42, issue.3, pp.602-611, 2006. ,
DOI : 10.1002/hep.21081
A case?control study of risk factors for hepatitis C infection in patients with unexplained routes of infection, Journal of Viral Hepatitis, vol.27, issue.11, pp.775-782, 2006. ,
DOI : 10.1023/A:1001988613235
A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assays, Journal of Immunological Methods, vol.260, issue.1-2, pp.157-172, 2002. ,
DOI : 10.1016/S0022-1759(01)00535-X
Adaptive immune responses to hepatitis C virus: from viral immunobiology to a vaccine, Biological Chemistry, vol.389, issue.5, pp.457-467, 2008. ,
DOI : 10.1515/BC.2008.061
Los Alamos Hepatitis C Immunology Database, Applied Bioinformatics, vol.25, issue.4, pp.217-225, 2005. ,
DOI : 10.2165/00822942-200504040-00002
Two subsets of memory T lymphocytes with distinct homing potentials and effector functions, Nature, vol.9, issue.6754, pp.708-712, 1999. ,
DOI : 10.1038/44385
Epitope Cross-Reactivity Frequently Differs between Central and Effector Memory HIV-Specific CD8+ T Cells, The Journal of Immunology, vol.178, issue.6, pp.3750-3756, 2007. ,
DOI : 10.4049/jimmunol.178.6.3750
Lymphocyte Reactivity to Hepatitis C Virus (HCV) Antigens Shows Evidence for Exposure to HCV in HCV???Seronegative Spouses of HCV???Infected Patients, The Journal of Infectious Diseases, vol.176, issue.2, pp.518-527, 1997. ,
DOI : 10.1086/517279
Comparison of cytotoxic T-lymphocyte responses to hepatitis C virus core protein in uninfected and infected individuals, Journal of Medical Virology, vol.133, issue.3, pp.239-246, 1999. ,
DOI : 10.1002/(SICI)1096-9071(199907)58:3<239::AID-JMV9>3.0.CO;2-V
Hepatitis C Virus???Specific Cytolytic T Lymphocyte and T Helper Cell Responses in Seronegative Persons, The Journal of Infectious Diseases, vol.176, issue.4, pp.859-867, 1997. ,
DOI : 10.1086/516546
Presence of effector CD8+ T cells in Hepatitis C virus exposed healthy seronegative donors, J Immunol, vol.162, pp.6681-6689, 1999. ,
Hepatitis C virus-specific T-cell immune responses in seronegative injection drug users, Journal of Viral Hepatitis, vol.44, issue.Suppl. 1, pp.10-20, 2009. ,
DOI : 10.1111/j.1365-2893.2008.01016.x
Clearance of Hepatitis C Viremia Associated with Cellular Immunity in the Absence of Seroconversion in the Hepatitis C Incidence and Transmission in Prisons Study Cohort, The Journal of Infectious Diseases, vol.189, issue.10, pp.1846-1855, 2004. ,
DOI : 10.1086/383279
Strong Hepatitis C Virus (HCV)-specific Cell-mediated Immune Responses in the Absence of Viremia or Antibodies Among Uninfected Siblings of HCV Chronically Infected Children, Journal of Infectious Diseases, vol.203, issue.6, pp.854-861, 2011. ,
DOI : 10.1093/infdis/jiq123
Gapped BLAST and PSI-BLAST: a new generation of protein database search programs, Nucleic Acids Research, vol.25, issue.17, pp.3389-3402, 1997. ,
DOI : 10.1093/nar/25.17.3389
Correlation between Interferon????? Secretion and Cytotoxicity, in Virus???Specific Memory T Cells, The Journal of Infectious Diseases, vol.190, issue.9, pp.1692-1696, 2004. ,
DOI : 10.1086/424490
A CD4+ Cytotoxic T- Lymphocyte Clone to a Conserved Epitope on Human Immunodeficiency Virus Type 1 p24: Cytotoxic Activity and Secretion of Interleukin-2 and Interleukin-6, J Virol, vol.66, pp.608-611, 1992. ,
Human Cytotoxic T-Cell Memory: Long-Lived Responses to Vaccinia Virus, J Virol, vol.70, pp.2627-2631, 1996. ,
Control of vaccinia virus skin lesions by long-term-maintained IFN-??+TNF-??+ effector/memory CD4+ lymphocytes in humans, Journal of Clinical Investigation, vol.120, issue.5, pp.1636-1644, 2010. ,
DOI : 10.1172/JCI38506
Cellular Immune Responses Associated with Occult Hepatitis C Virus Infection of the Liver, Journal of Virology, vol.80, issue.22, pp.10972-10979, 2006. ,
DOI : 10.1128/JVI.00852-06
Occult Hepatitis C Virus Infection in Patients in Whom the Etiology of Persistently Abnormal Results of Liver???Function Tests Is Unknown, The Journal of Infectious Diseases, vol.189, issue.1, pp.7-14, 2004. ,
DOI : 10.1086/380202
Prevalence of liver fibrosis and risk factors in a general population usng non-invasive biomarkers (Fibrotest), BMC Gastroenterol, vol.10, p.4, 2010. ,
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance, Nature, vol.18, issue.7262, pp.369-401, 2009. ,
DOI : 10.1038/nature08309
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus, Nature, vol.119, issue.7265, pp.798-802, 2009. ,
DOI : 10.1038/nature08463
IL28B genetic polymorphism testing in the era of direct acting antivirals therapy for chronic hepatitis C: ten years too late?, Liver International, vol.54, issue.Suppl. 1, pp.74-78, 2012. ,
DOI : 10.1111/j.1478-3231.2011.02712.x
The core-specific precursor T cell response is directed to the N-terminal and central parts of the protein and positively correlates to the viral load in chronically HCV-infected patients, Virology, vol.340, issue.2, pp.318-325, 2005. ,
DOI : 10.1016/j.virol.2005.06.031
URL : https://hal.archives-ouvertes.fr/pasteur-00013706
Hepatitis C databases, principles and utility to researchers, Hepatology, vol.86, issue.5, pp.1157-1165, 2006. ,
DOI : 10.1002/hep.21162
URL : https://hal.archives-ouvertes.fr/hal-00313672
The Los Alamos hepatitis C sequence database, Bioinformatics, vol.21, issue.3, pp.379-384, 2005. ,
DOI : 10.1093/bioinformatics/bth485
A vaccinia-based elispot assay for detection of CD8+ T cells from HIV-1 infected children, Journal of Immunological Methods, vol.298, issue.1-2, pp.105-118, 2005. ,
DOI : 10.1016/j.jim.2005.01.003
URL : https://hal.archives-ouvertes.fr/pasteur-00013703